Pharmaceutical combination and use thereof
US-2024189341-A1 · Jun 13, 2024 · US
Bordetella outer-membrane protein antigens and methods of making and using the same
US9283268B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9283268-B2 |
| Application number | US-201414498537-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 26, 2014 |
| Priority date | Oct 25, 2007 |
| Publication date | Mar 15, 2016 |
| Grant date | Mar 15, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
An isolated protein or peptide selected from the group consisting of Bordetella colonization factor A (BcfA) protein and antigenic fragments thereof is described, along with an isolated nucleic acid encoding the same, antibodies that bind to the same, methods of producing an immune response in a mammalian subject in need thereof by administering the proteins, peptides or antibodies, and pharmaceutical compositions comprising the same.
First claim
Opening claim text (preview).
That which is claimed is: 1. A method of treating a mammalian subject for a Bordetella infection, comprising administering said subject an antibody in a treatment effective amount, wherein said antibody binds to Bordetella colonization factor A (BcfA) protein fragment consisting of 20 to 500 consecutive amino acids of either SEQ ID NO: 2 or SEQ ID NO:3. 2. The method of claim 1 , wherein said Bordetella infection is a Bordetella bronchiseptica or Bordetella pertussis infection. 3. The method of claim 1 , wherein said Bordetella infection is a Bordetella bronchiseptica infection. 4. The method of claim 1 , wherein said Bordetella infection is a Bordetella pertussis infection.
Assignees
Inventors
Classifications
from Bordetella (G) · CPC title
humoral response · CPC title
Antibacterial agents · CPC title
Immunostimulants · CPC title
- A61K39/099Primary
Bordetella · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9283268B2 cover?
- An isolated protein or peptide selected from the group consisting of Bordetella colonization factor A (BcfA) protein and antigenic fragments thereof is described, along with an isolated nucleic acid encoding the same, antibodies that bind to the same, methods of producing an immune response in a mammalian subject in need thereof by administering the proteins, peptides or antibodies, and pharm…
- Who is the assignee on this patent?
- Univ Wake Forest Health Sciences
- What technology area does this patent fall under?
- Primary CPC classification A61K39/099. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).